Urine Drug Testing among Medicaid Enrollees Initiating Buprenorphine Treatment for Opioid Use Disorder within 9 MODRN States
09/01/2023
Treatment guidelines recommend regular urine drug testing (UDT) for persons initiating buprenorphine for opioid use disorder (OUD). However, little is known about UDT utilization. This study describes state variation in UDT utilization and examines demographic, health, and health care utilization factors associated with UDT in Medicaid.
Senior Policy Analyst Shamis Mohamoud was part of the Medicaid Outcomes Distributed Research Network (MODRN) team of authors of this article published in Drug and Alcohol Dependence.